Alpha Cognition (ACOG) to Release Quarterly Earnings on Thursday

Key Points

• Alpha Cognition will report its Q1 2026 results after the market closes on Thursday, May 14, with an earnings call at 4:30 PM ET; analysts expect EPS of ($0.41) and revenue of $3.423 million.
• The company missed estimates last quarter (reported ($0.30) vs. expected ($0.27)), has a deeply negative net margin (202.23%) and ROE (-55.71%), and analysts forecast about -$1 EPS for the current fiscal year and $0 for the next.
• Shares trade around $6.38 with a market cap of ~$138.9M, and Wall Street has a consensus Buy rating with a $16.00 target (analyst targets range roughly $14–$18); several hedge funds have recently added positions.

Alpha Cognition (NASDAQ:ACOG - Get Free Report) is projected to release its Q1 2026 results after the market closes on Thursday, May 14th. Analysts expect Alpha Cognition to post earnings of ($0.41) per share and revenue of $3.4230 million for the quarter. Investors may review the information on the company's upcoming Q1 2026 earning report for the latest details on the call scheduled for Thursday, May 14, 2026 at 4:30 PM ET.

Alpha Cognition (NASDAQ:ACOG - Get Free Report) last posted its quarterly earnings data on Thursday, March 26th. The company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.03). Alpha Cognition had a negative net margin of 202.23% and a negative return on equity of 55.71%. The firm had revenue of $2.60 million for the quarter, compared to analysts' expectations of $4.41 million. On average, analysts expect Alpha Cognition to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Alpha Cognition Price Performance

Shares of ACOG opened at $6.38 on Thursday. The company has a 50-day moving average of $6.08 and a two-hundred day moving average of $5.97. The stock has a market cap of $138.92 million, a price-to-earnings ratio of -5.50 and a beta of 2.38. Alpha Cognition has a one year low of $4.50 and a one year high of $11.54.

Institutional Trading of Alpha Cognition

A number of hedge funds have recently made changes to their positions in ACOG. Geode Capital Management LLC acquired a new stake in shares of Alpha Cognition during the second quarter worth approximately $112,000. Massar Capital Management LP acquired a new position in Alpha Cognition in the 2nd quarter valued at approximately $116,000. Two Sigma Investments LP purchased a new stake in Alpha Cognition in the 3rd quarter worth approximately $148,000. Boothbay Fund Management LLC lifted its position in Alpha Cognition by 10.8% in the 3rd quarter. Boothbay Fund Management LLC now owns 291,868 shares of the company's stock worth $1,900,000 after buying an additional 28,392 shares in the last quarter. Finally, Connective Capital Management LLC acquired a new stake in shares of Alpha Cognition during the 3rd quarter valued at $312,000.

Wall Street Analysts Forecast Growth

ACOG has been the subject of several research analyst reports. HC Wainwright restated a "buy" rating and issued a $18.00 price target on shares of Alpha Cognition in a research report on Monday, April 27th. Wall Street Zen downgraded shares of Alpha Cognition from a "hold" rating to a "sell" rating in a research note on Saturday, May 2nd. Finally, Craig Hallum started coverage on Alpha Cognition in a report on Friday, April 17th. They issued a "buy" rating and a $14.00 target price for the company. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $16.00.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.